THE CLINICAL AND IMMUNOLOGICAL EFFECTS OF ANTI-B-CELL THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS von Aleksandrova, Elena Nikolayevna, Avdeyeva, A S, Lukina, G V, Novikov, A A, Cherkasova, M V, Popkova, T V, Lineva, O G, Kuzikyants, G Kh, Nasonov, E L

Volltext

ROLE OF MULTIPLEX CYTOKINE ANALYSIS IN THE EVALUATION OF THE EFFICACY OF RITUXIMAB DURING TREATMENT FOR RHEUMATOID ARTHRITIS von Novikov, A. A., Aleksandrova, E. N., Popkova, T. V., Lineva, O. G., Avdeyeva, A. S., Novikova, D. S., Kuzikyants, G. Kh, Lukina, G. V., Sigidin, Ya. A., Karaulov, A. V., Bykovskaya, S. N., Nasonov, E. L.

Volltext

FRI0157 Discrepancies Between Clinical and Antidestructive Effects of Rituximab in Rheumatoid Arthritis (RA) von Pivanova, A.V., Lukina, G.V., Sigidin, Ya.A., Smirnov, A.V., Kuzikyants, K.H., Kuznetsova, A.Yu, Nasonov, E.L.

Volltext

AB0529 Rituximab therapy monitoring by mtor, autophagy-related ULK1, caspase 3, CDK-inhibitor P21, TNF alpha, and osteoclast-specific cathepsin K and gelatinase MMP-9 gene expressi... von Tchetina, E.V., Kuzikyants, K.H., Devyataikina, A.Y., Lukina, G.V., Nasonov, E.L.

Volltext

A4.9Effect of different doses of Rituximab on the progression of bone destruction in rheumatoid arthritis (RA) von Pivanova, A V, Lukina, G V, Sigidin, YA, Smirnov, A V, Kuzikyants, KH, Kuznetsova, A Y, Nasonov, EL

Volltext

A4.9 Effect of different doses of Rituximab on the progression of bone destruction in rheumatoid arthritis (RA) von Pivanova, AV, Lukina, GV, Sigidin, YA, Smirnov, AV, Kuzikyants, KH, Kuznetsova, AY, Nasonov, EL

Volltext

A7.12 Analysis of clinical and antidestructive effects of rituximab in rheumatoid arthritis: Preliminary data von Pivanova, AV, Lukina, GV, Sigidin, YaA, Smirnov, AV, Kuzikyants, KH, Kuznetsova, AYu, Gluκhova, SI, Nasonov, EL

Volltext

RITUXIMAB THERAPY MONITORING IN PATIENTS WITH RHEUMATOID ARTHRITIS HROUGH PERIPHERAL BLOOD GENE EXPRESSION ANALYSIS von E. V. Chetina, A. V. Pivanova, K. Kh. Kuzikyants, A. Yu. Devyataikina, G. V. Lukina, E. Yu. Samarkina, A. P. Aleksankin, E. N. Aleksandrova

Volltext

Impact of rituximab therapy on endothelial function and other markers of atherosclerosisin patients with active rheumatoid arthritis von Volkov, Aleksandr Vital'evich, Lineva, O G, Kuzikyants, K Kh, Lukina, G V, Nasonov, E L, Volkov, Aleksandr Vitalyevich

Volltext

THE RUSSIAN REGISTRY OF RITUXIMAB. ANALYSIS OF THE EFFICIENCY OF THERAPY AND THE FUNCTIONAL STATEOF PATIENTS WITH RHEUMATOID ARTHRITIS von Amirdzhanova, Vera Nikolayevna, Goryachev, D V, Lukina, G V, Kuzikyants, K Kh, Nasonov, E L

Volltext

Experience with long-term infliximab therapy in patients with ankylosing spondylitis von Rumyantseva, Oksana Alekseevna, Bochkova, A G, Kuzikyants, K Kh, Levshakova, A V, Erdes, Sh F, Nasonov, E L, Rumyantseva, Oksana Alekseyevna

Volltext

Pervyy opyt primeneniya monoklonal'nykh antitel k V-limfotsitam (Rituksimab) pri revmatoidnom artrite v Rossii von G V Lukina, E L Nasonov, Ya A Sigidin, K Kh Kuzikyants, L. L. Bazevich, T I Zlobnna, R G Kamalova, L A Knyazeva, V I Mazurov, L V Men'shikova, A E Sizikov, E A Smirnova, N A Fofonova, T V Shabalina, L M Shkil', N V Yudina, S S Yakushin

Volltext